Racial and sex disparities in hepatocellular carcinoma in the USA

F Ajayi, J Jan, AG Singal, NE Rich - Current hepatology reports, 2020 - Springer
Abstract Purpose of Review In this review, we aim to provide a summary of the current
literature on race and gender disparities in hepatocellular carcinoma (HCC) incidence …

Effect of fragmentation of cancer care on treatment use and survival in hepatocellular carcinoma

CA Hester, N Karbhari, NE Rich, M Augustine… - Cancer, 2019 - Wiley Online Library
Background Fragmented cancer care (FC), or care received from multiple institutions,
increases systemic health care costs and potentiates cancer care disparities. There is a …

[HTML][HTML] Liver cancer: A leading cause of cancer death in the United States and the role of the 1945–1965 birth cohort by ethnicity

PS Pinheiro, KE Callahan, PD Jones, C Morris… - JHEP Reports, 2019 - Elsevier
Background & Aims Liver cancer is highly fatal and the most rapidly increasing cancer in the
US, where chronic hepatitis C (HCV) infection is the leading etiology. HCV is particularly …

Burden of liver cancer mortality by county, race, and ethnicity in the USA, 2000–19: a systematic analysis of health disparities

H Nassereldine, K Compton, P Kendrick, Z Li… - The Lancet Public …, 2024 - thelancet.com
Background Understanding how specific populations are affected by liver cancer is
important for identifying priorities, policies, and interventions to mitigate health risks and …

Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma

RP Thylur, SK Roy, A Shrivastava, TA LaVeist… - JGH …, 2020 - Wiley Online Library
Despite improved screening and surveillance guidelines, significant race/ethnicity‐specific
disparities in hepatocellular carcinoma (HCC) continue to exist and disproportionately affect …

Glycopeptides with Sialyl Lewis antigen in serum haptoglobin as candidate biomarkers for nonalcoholic steatohepatitis hepatocellular carcinoma using a higher …

Y Lin, J Zhu, J Zhang, J Dai, S Liu, A Arroyo, M Rose… - ACS …, 2022 - ACS Publications
Nonalcoholic steatohepatitis (NASH) is the fastest growing cause of hepatocellular
carcinoma (HCC) in the United States. Changes in N-glycosylation on specific glycosites of …

Long non‐coding RNA H19 as a biomarker for hepatocellular carcinoma

Á Rojas, A Gil‐Gómez, P de la Cruz‐Ojeda… - Liver …, 2022 - Wiley Online Library
Abstract Background and Aims Liver cancer stem cells (CSCs) could be involved in the
carcinogenesis, recurrence, metastasis and chemoresistance of hepatocellular carcinoma …

A panel of glycopeptides as candidate biomarkers for early diagnosis of NASH hepatocellular carcinoma using a stepped HCD method and PRM evaluation

Y Lin, J Zhu, L Pan, J Zhang, Z Tan… - Journal of proteome …, 2021 - ACS Publications
Changes in N-glycosylation on specific peptide sites of serum proteins have been
investigated as potential markers for diagnosis of nonalcoholic steatohepatitis (NASH) …

Comparative analysis of nonalcoholic steatohepatitis–versus viral hepatitis–and alcohol-related liver disease–related hepatocellular carcinoma

CA Hester, NE Rich, AG Singal, AC Yopp - Journal of the National …, 2019 - jnccn.org
Background: Despite an increasing burden of nonalcoholic steatohepatitis (NASH), limited
data are available comparing outcomes of NASH-related hepatocellular carcinoma (HCC) …

County differences in liver mortality in the United States: impact of sociodemographics, disease risk factors, and access to care

D Goldberg, K Ross-Driscoll, R Lynch - Gastroenterology, 2021 - Elsevier
Background and Aims Data have demonstrated state-wide variability in mortality rates from
liver disease (cirrhosis+ hepatocellular carcinoma), but data are lacking at the local level …